| Literature DB >> 30785029 |
Kristyna Pivovarcikova1, Petr Martinek1, Petr Grossmann1, Kiril Trpkov2, Reza Alaghehbandan3, Cristina Magi-Galluzzi4, Maria Pane Foix5, Enric Condom Mundo5, Daniel Berney6, Anthony Gill7, Boris Rychly8, Kvetoslava Michalova1, Joanna Rogala9, Tomas Pitra10, Tamas Micsik11, Jiri Polivka12, Milan Hora10, Ozlem Tanas Isikci13, Sarka Skalova1, Jana Mareckova1, Michal Michal1, Ondrej Hes14.
Abstract
Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma (HLRCC)/fumarate hydratase deficient renal cell carcinoma (FHRCC) is defined by molecular genetic changes (mutation/LOH in fumarate hydratase (FH) gene). We investigated chromosomal numerical aberration pattern (CNV) in FHRCC/HLRCC using array comparative genomic hybridization analysis and low pass whole genome sequencing. Genetic analysis was successfully completed in 12 tumors. Most common chromosomal aberrations detected were a complete or partial loss of chromosome 4 (5/12 cases), chromosome 15 (4/12 cases), and chromosomes 9, 13, and 14 (each in 3/12 cases), as well as a complete or partial gain of chromosome 17 (in 4/12 cases). No chromosomal losses or gains were detected in 4 cases. Copy number variation pattern in FHRCC/HLRCC appears to be highly variable and does not provide a useful diagnostic tool in identifying these cases. Immunohistochemical staining and especially molecular genetic evaluation of FH gene mutations/LOH remain the gold standard in identifying FHRCC/HLRCC.Entities:
Keywords: Chromosomal numerical aberration pattern; Fumarate hydratase deficient renal cell carcinoma; Kidney
Mesh:
Substances:
Year: 2019 PMID: 30785029 DOI: 10.1016/j.anndiagpath.2019.02.008
Source DB: PubMed Journal: Ann Diagn Pathol ISSN: 1092-9134 Impact factor: 2.090